| Psychology and Behavioral Sciences | Lifetime | 812 | US 503 | 99.67 |
| Psychology and Behavioral Sciences | 2021-2025 | 564 | US 197 | 98.59 |
| Clinical Pharmacology | Lifetime | 35 | US 16 | 99.84 |
| Cellular and Molecular Neuroscience | Lifetime | 154 | US 89 | 99.47 |
| Clinical Psychology | Lifetime | 415 | US 280 | 99.48 |
| Biological Psychiatry | Lifetime | 23 | US 13 | 98.62 |
| Psychiatry and Mental health | Lifetime | 380 | US 195 | 98.78 |
| Cognitive Neuroscience | Lifetime | 580 | US 298 | 98.64 |
| Cognitive Psychology | Lifetime | 958 | US 520 | 96.76 |
| Behavioral Neuroscience | Lifetime | 213 | US 128 | 93.86 |
| Philosophy of Mind, Language and Cognitive Science | Lifetime | 565 | US 240 | 92.17 |
| Clinical Pharmacology | 2021-2025 | 56 | US 20 | 98.03 |
| Clinical Psychology | 2021-2025 | 265 | US 100 | 98.02 |
| Cognitive Neuroscience | 2021-2025 | 479 | US 201 | 90.94 |
| Psychiatry and Mental health | 2021-2025 | 478 | US 183 | 86.87 |
| Cellular and Molecular Neuroscience | 2021-2025 | 288 | US 118 | 73.82 |
| Tryptophan and brain disorders | Lifetime | 10 | US 5 | 99.92 |
| Treatment of Major Depression | Lifetime | 7 | US 5 | 99.89 |
| Neuroscience and Neuropharmacology Research | Lifetime | 139 | US 78 | 99.75 |
| Neurotransmitter Receptor Influence on Behavior | Lifetime | 94 | US 56 | 99.45 |
| Functional Brain Connectivity Studies | Lifetime | 175 | US 88 | 99.52 |
| Schizophrenia research and treatment | Lifetime | 253 | US 121 | 99.07 |
| Stress Responses and Cortisol | Lifetime | 331 | US 186 | 98.68 |
| Anesthesia and Neurotoxicity Research | Lifetime | 305 | US 157 | 97.95 |
| Posttraumatic Stress Disorder Research | Lifetime | 121 | US 75 | 98.36 |
| COVID-19 and Mental Health | Lifetime | 452 | US 113 | 96.74 |
| Memory and Neural Mechanisms | Lifetime | 314 | US 177 | 98.23 |
| Healthcare professionals’ stress and burnout | Lifetime | 271 | US 108 | 96.90 |
| Mental Health Research Topics | Lifetime | 442 | US 249 | 97.92 |
| Alcohol Consumption and Health Effects | Lifetime | 460 | US 227 | 96.81 |
| Bipolar Disorder and Treatment | Lifetime | 554 | US 239 | 97.04 |
| Traumatic Brain Injury Research | Lifetime | 589 | US 369 | 96.00 |
| Substance Abuse Treatment and Outcomes | Lifetime | 669 | US 464 | 96.24 |
| Nicotinic Acetylcholine Receptors Study | Lifetime | 852 | US 425 | 94.43 |
| Resilience and Mental Health | Lifetime | 850 | US 420 | 93.81 |
| Alcoholism and Thiamine Deficiency | Lifetime | 419 | US 195 | 91.52 |
| Electroconvulsive Therapy Studies | Lifetime | 557 | US 256 | 92.29 |
| Psychedelics and Drug Studies | Lifetime | 624 | US 246 | 86.03 |
| Hallucinations in medical conditions | Lifetime | 277 | US 68 | 66.10 |
| Tryptophan and brain disorders | 2021-2025 | 44 | US 8 | 98.43 |
| Treatment of Major Depression | 2021-2025 | 18 | US 6 | 98.42 |
| Neuroscience and Neuropharmacology Research | 2021-2025 | 547 | US 195 | 91.62 |
| Mental Health Research Topics | 2021-2025 | 489 | US 157 | 92.53 |
| Posttraumatic Stress Disorder Research | 2021-2025 | 185 | US 97 | 91.45 |
| Schizophrenia research and treatment | 2021-2025 | 687 | US 150 | 88.88 |
| Anesthesia and Neurotoxicity Research | 2021-2025 | 360 | US 91 | 83.86 |
| Healthcare professionals’ stress and burnout | 2021-2025 | 738 | US 157 | 84.40 |
| Memory and Neural Mechanisms | 2021-2025 | 568 | US 262 | 80.74 |
| Psychedelics and Drug Studies | 2021-2025 | 658 | US 228 | 65.35 |
| Identity, Memory, and Therapy | 2021-2025 | 272 | US 89 | 63.69 |
| Nicotinic Acetylcholine Receptors Study | 2021-2025 | 773 | US 267 | 58.75 |
